X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

比特币 ¥762,228.82 -0.30%
以太坊 ¥18,405.36 -2.00%
币安币 ¥4,693.32 +0.21%
Optimism ¥4.15 -3.84%
Arbitrum ¥2.27 -6.15%
Solana ¥1,092.75 -2.82%
Polygon ¥1.56 +2.77%
Cosmos ¥29.58 -1.53%
Avalanche ¥136.77 -3.26%

比特币 ¥762,228.82 -0.30%
以太坊 ¥18,405.36 -2.00%
币安币 ¥4,693.32 +0.21%
Optimism ¥4.15 -3.84%
Arbitrum ¥2.27 -6.15%
Solana ¥1,092.75 -2.82%
Polygon ¥1.56 +2.77%
Cosmos ¥29.58 -1.53%
Avalanche ¥136.77 -3.26%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed